Related Experiment Video
Updated: Jan 9, 2026

Surgical Procedures and Methodology for a Preclinical Murine Model of De Novo Mammary Cancer Metastasis
Published on: July 29, 2017
A Case Report of Short-Term Metastasis After Surgery for Mammary Paget's Disease
Chao Wang1, Baiyi Yan1, Jing Wang1
1Department of Breast Cancer Beijing Arion Cancer Center Beijing China.
Abstract:
Mammary Paget's disease (MPD) with ductal carcinoma in situ (DCIS) pathology can metastasize rapidly. HER2-positive status likely drives aggression, warranting early postoperative systemic imaging and close surveillance. Anti-HER2 agents require proactive toxicity management. Personalized dose adjustments and multidisciplinary management are essential to optimize outcomes.
Insights
Mammary Paget's disease (MPD) with ductal carcinoma in situ (DCIS) can spread quickly. Early imaging, surveillance, and managing anti-HER2 agent side effects are crucial for better patient outcomes.
Area of Science:
- Oncology
- Breast Cancer Research
Background:
- Mammary Paget's disease (MPD) often co-occurs with ductal carcinoma in situ (DCIS).
- Rapid metastasis is a significant concern in MPD with DCIS.
- HER2-positive status is linked to aggressive disease progression.
Purpose of the Study:
- To highlight the aggressive nature of HER2-positive MPD with DCIS.
- To emphasize the need for prompt diagnostic and surveillance strategies.
- To outline essential management principles for optimizing patient outcomes.
Main Methods:
- Review of clinical presentations and pathological findings in MPD with DCIS.
- Analysis of the impact of HER2 status on disease behavior.
- Discussion of treatment modalities and supportive care strategies.
Main Results:
- MPD with DCIS, particularly HER2-positive cases, demonstrates a propensity for rapid metastasis.
- Early systemic imaging and vigilant surveillance are critical postoperatively.
- Anti-HER2 therapies necessitate careful toxicity monitoring and management.
Conclusions:
- Aggressive management is required for HER2-positive MPD with DCIS.
- Personalized dose adjustments and multidisciplinary care are key to successful treatment.
- Proactive management of treatment-related toxicities improves patient outcomes.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
05:05Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018